Physician profile
David E Rosman
NPI 1649255217
$4,327.08
in general payments reported to CMS, 2019-2025
35 companies · $732 in 2025
The $732 reported for 2025 was more than what 85% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $161 · 2021: $338 · 2022: $529 · 2023: $838 · 2024: $1,125 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,694.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $524.50 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $513.75 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $490.94 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $376.11 | 2019-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $285.08 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Pfizer INC. | $230.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $204.60 | 2019-2025 | Capvaxive, Vaxneuvance, Pneumovax 23 |
| Novartis Pharmaceuticals Corporation | $175.06 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $144.20 | 2023-2024 | Xifaxan |
| Cequr Corporation | $141.07 | 2024 | Cequr Simplicity |
| Glaxosmithkline, LLC. | $132.79 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.45 | 2021-2024 | Jardiance |
| Amarin Pharma, INC. | $109.79 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $104.54 | 2022-2024 | |
| Abbott Laboratories | $102.88 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $90.19 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sanofi Pasteur INC. | $71.39 | 2020-2023 | |
| Radius Health, INC. | $62.65 | 2019 | |
| Axsome Therapeutics, INC. | $55.72 | 2024-2025 | Auvelity |
| Amneal Pharmaceuticals LLC | $48.35 | 2022-2024 | Unithroid |
| Esperion Therapeutics, INC. | $37.61 | 2023-2025 | Nexletol |
| Seqirus USA INC | $35.85 | 2022-2024 | Fluad, Flucelvax |
| Actelion Pharmaceuticals US, INC. | $34.49 | 2024-2025 | Opsumit, Uptravi |
| Daiichi Sankyo INC. | $32.57 | 2021-2024 | Injectafer |
| Janssen Pharmaceuticals, INC | $32.11 | 2019 | |
| Medicomp INC | $21.64 | 2024 | Telepatch Cardiac Monitor |
| Medline Industries Lp | $20.60 | 2019 | |
| Si-Bone, INC. | $18.87 | 2023 | |
| Genzyme Corporation | $16.29 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.80 | 2024 | Eliquis |
| Idorsia Pharmaceuticals US INC | $15.70 | 2023 | Quviviq |
| Dexcom, INC. | $15.17 | 2023 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $13.88 | 2020 | |
| Lucid Diagnostics INC. | $13.19 | 2023 | |
| Vivaquant INC, Dba Rhythm Express | $10.81 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rosman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.